Antihypertensive action of trandolapril and verapamil in spontaneously hypertensive rats after unilateral nephrectomy

• Published in: Journal of cardiovascular pharmacology Vol. 32; no. 2; p. 284
• Main Authors: López-Hernández, F J, Flores, O, López-Novoa, J M, Montero, M J, Carrón, R
• Format: Journal Article
• Language: English
• Published: United States 01.08.1998
• Subjects: Acetylcholine - pharmacology; Animals; Antihypertensive Agents - therapeutic use; Aorta; Blood Pressure - drug effects; Female; Heart - drug effects; Heart - physiology; Hypertension - drug therapy; Hypertension - physiopathology; Indoles - therapeutic use; Nephrectomy; Nitroprusside - pharmacology; Norepinephrine - pharmacology; Potassium Chloride - pharmacology; Rats; Rats, Inbred SHR - surgery; Vasoconstriction - drug effects; Vasodilator Agents - therapeutic use; Verapamil - therapeutic use
• ISSN: 0160-2446
• DOI: 10.1097/00005344-199808000-00016

It is well documented that the kidney plays a fundamental role in long-term arterial pressure regulation, and, as an endocrine organ, in the regulation of cardiovascular structure and functionality. In this study, the antihypertensive effect of long-term treatment (6 months) with placebo, verapamil, trandolapril, and a combination of the latter (verapamil plus trandolapril) was investigated in spontaneously hypertensive rats after half-renal-mass ablation. Arterial pressure was monitored during treatment and at the end, aortic structure and functionality were investigated. Trandolapril and the combination returned pressure to normal, whereas verapamil was less effective. All three treatment groups were similarly effective at reducing aortic medial hypertrophy, the wall-to-lumen ratio, and contraction evoked by potassium chloride and noradrenaline. Verapamil and veratran were more effective than trandolapril at reducing lamina media cross-sectional area. Trandolapril and the combination were more effective than verapamil at improving endothelial dysfunction.